10 Biggest Mid-Day Gainers For Monday

Loading...
Loading...

 

  • CIFC LLC CIFC shares climbed 58.9 percent to $10.98 after the company agreed to be acquired by F.A.B. Partners for $333 million in cash.
  • RLJ Entertainment Inc RLJE shares gained 58.2 percent to $3.10. RLJ Entertainment shares have climbed 67.44 percent over the past 52 weeks, while the S&P 500 index has gained 15.35 percent in the same period.
  • StemCells Inc STEM shares rose 43.6 percent to $1.78. StemCells shares have dropped 72.81 percent over the past 52 weeks, while the S&P 500 index has gained 15.35 percent in the same period.
  • Lantronix Inc LTRX gained 24.8 percent to $1.60. Lantronix reported the launch of a new premier partner program, Lantronix SmartAdvantage. The company is expected to report its Q4 financial results on August 23, 2016.
  • Cyclacel Pharmaceuticals Inc CYCC shares rose 23 percent to $8.52. Tang Capital Partners disclosed a 9.6 percent passive stake in Cyclacel Pharmaceuticals, according to a regulatory filing.
  • Medivation Inc MDVN shares surged 19.7 percent to $80.41. Pfizer Inc PFE and Medivation struck a definitive deal through which the former would buy the latter for $81.50 a share in cash.
  • Intersil Corp ISIL shares gained 19.6 percent to $18.71 following a report it was near a deal to be acquired by Renesas Electronics for up to $2.99 billion.
  • Syngenta AG (ADR) SYT gained 10.3 percent to $87.73 after a U.S. national security panel cleared its acquisition by ChemChina.
  • Valeant Pharmaceuticals Intl Inc VRX rose 8.1 percent to $31.07. Valeant Pharma named Paul Herendeen as new CFO.
  • Cardiovascular Systems Inc CSII gained 4.8 percent to $23.69. Leerink Swann upgraded Cardiovascular Systems from Market Perform to Outperform.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsIntraday UpdateMarketsMoversCommunications EquipmentInformation TechnologyTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...